Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas

The presence of an isocitrate dehydrogenase (IDH1/2) mutation in gliomas is associated with favorable outcomes compared to gliomas without the mutation (IDH1/2 wild-type, WT). The underlying biological mechanisms accounting for improved clinical outcomes in IDH1/2 mutant gliomas remain poorly unders...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Beyer, Sasha J., Bell, Erica H., McElroy, Joseph P., Fleming, Jessica L., Cui, Tiantian, Becker, Aline, Bassett, Emily, Johnson, Benjamin, Gulati, Pooja, Popp, Ilinca, Staszewski, Ori, Prinz, Marco, Grosu, Anca L., Haque, Saikh Jaharul, Chakravarti, Arnab
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324682/
https://ncbi.nlm.nih.gov/pubmed/30647847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados